GLP2R
2 papers
- Human trial2
Latest
1 in 12 monthsADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Extended-Interval PG-102, a GLP-1/GLP-2 Bispecific Agonist, in Adults with Type 2 Diabetes
Randomised trial in 48 peopleType 2 diabetes
ADA Scientific Sessions 2025 Abstract
Safety, Tolerability, and Clinical Effects of Dapiglutide, a Once-Weekly GLP-1R/GLP-2R Agonist
Randomised trial in 54 peopleInterventions